论文部分内容阅读
分析46例喉癌术后远期疗效,3年及5年生存率,声门型为74.2％和83.3％、声门上型为50.0％和55.6％,全喉切除术为43.8％和77.8％,部分喉切除术为83.3％和85.7％。认为声门上型喉癌术后短期内使用大剂量化疗有助于提高疗效。探讨切缘是否残留肿瘤及鳞癌的分化程度与疗效的关系。指出在选择术式时要考虑到术中所见的肿瘤范围比术前检查所见要广泛这一因素。
To analyze the long-term outcomes, the 3-year and 5-year survival rates of 46 patients with laryngeal carcinoma, the glottic type was 74.2% and 83.3%, the supraglottic type was 50.0% and 55.6%, and the total laryngectomy was 43.8% and 77.8% Partial laryngectomy was 83.3% and 85.7%. It is believed that the use of high-dose chemotherapy in the short term after surgery for supraglottic laryngeal cancer may help improve the efficacy. To investigate whether the margin of residual tumor and squamous cell carcinoma is related to the efficacy of differentiation. It was pointed out that when choosing the surgical method, the factors that the range of tumors seen during the operation should be wider than those seen before the preoperative examination must be considered.